Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minirin Melt Dose-Response in Japanese Nocturia Patients
NCT01184859Phase 2Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Jul 2010
- Primary completion
- Apr 2011
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of desmopressin in nocturia, sponsored by Ferring Pharmaceuticals. Started Jul 2010; status: completed.
02
Drugs
desmopressin
03
Conditions
nocturia
Beyond the preview
Go deeper on NCT01184859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01184859.